Skip to main content
. 2019 Feb 1;11(2):63. doi: 10.3390/pharmaceutics11020063

Figure 6.

Figure 6

(A) In vivo biodistribution pattern of Cy5.5/F127&P123 and Cy5.5/F127&P123-Tf in MDA-MB-231(R) tumor-bearing mice; (B) ex vivo tissue distribution of Cy5.5/F127&P123 and Cy5.5/F127&P123-Tf in (i) heart, (ii) liver, (iii) spleen, (iv) lungs, (v) kidneys, and (vi) tumor excised from MDA-MB-231(R) tumor-bearing mice; (C) quantification of fluorescent signals from part B; data shown represent mean ± SD (n = 3).